Acta Scientific Microbiology (ISSN: 2581-3226)

Short Communication Volume 5 Issue 11

Therapeutic Monoclonal Antibodies Approved by FDA in 2021

Henry Hongrong Cai* and Ayesha Pandit

Premier Research, 3800 Paramount Parkway, Morrisville, NC, USA

*Corresponding Author: Henry Hongrong Cai, Premier Research, 3800 Paramount Parkway, Morrisville, NC, USA.

Received: October 19, 2022; Published: October 27, 2022

Abstract

AMD: Age-Related Macular Degeneration; ANGPTL3: Angiopoietin-like 3; ARIA: Amyloid Related Imaging Abnormalities; AS: Ankylosing Spondylitis; ATE f: Arterial Thromboembolic Even; CD: Crohn’s Disease; CR: Cutaneous Reactions; DAE: Dermatologic Adverse Reactions; DLBCL: Diffuse Large B-cell Lymphoma; dMMR EC: Mismatch Repair Deficient Endometrial Cancer; EE: Effusion and Edema; EFT: Embryo-Fetal Toxicity; EGFR: Epidermal Growth Factor Receptor; ERD: Endophthalmitis and Retinal Detachment; HoFH: Homozygous Familial Hypercholesterolemia (HoFH); HR: Hypersensitivity Reactions; (I)INFR: Type I Interferon Receptor; IIOP: Increases in Intraocular Pressure; ILD: Interstitial Lung Disease; ILI: Influenza-like Illness; IMAE: Immune-mediated Adverse Reactions; IRR: Infusion-related Reactions; JIA: Juvenile Idiopathic Arthritis; LBCL: Large B-cell Lymphoma; LDL-C: Low-Density Lipoprotein-Cholesterol; mCNV: Myopic Choroidal Neovascularization; MET: Receptor MET Also Known as Hepatocyte Growth Factor Receptor; MS: Myelosuppression; NSCLC: Non-Small Cell Lung Cancer; OT: Ocular Toxicity; PD-1: Programmed Death Receptor-1; PN: Peripheral Neuropath; Ps: Plaque Psoriasis; PsA: Psoriatic Arthritis; RA: Rheumatoid Arthritis; RVO: Retinal Vein Occlusion; SHR: Serious Hypersensitivity Reactions; SI: Serious Infections; SLE: Systemic Lupus Erythematosus; TNF: Tumor Necrosis Factor; TSLP: Thymic Stromal Lymphopoietin; URTI: Upper Respiratory Tract Infections; UC: Ulcerative Colitis; VEGF: Vascular Endothelial Growth Factor

References

  1. https://asclepiusopen.com/clinical-research-in-immunology/volume-4-issue-1/1.pdf
  2. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761181s000lbl.pdf
  3. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761174s000lbl.pdf
  4. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761196s000lbl.pdf
  5. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761210s001lbl.pdf
  6. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761178s003lbl.pdf
  7. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761123s000lbl.pdf
  8. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761223s000lbl.pdf
  9. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761202s000lbl.pdf
  10. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761208Orig1s000lbledt.pdf
  11. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761197s000lbl.pdf
  12. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761216s000lbl.pdf
  13. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761224s000lbl.pdf
  14. Label for ADBRY not available yet.

Citation

Citation: Henry Hongrong Cai and Ayesha Pandit. “Therapeutic Monoclonal Antibodies Approved by FDA in 2021". Acta Scientific Microbiology 5.11 (2022): 81-83.

Copyright

Copyright: © 2022 Henry Hongrong Cai and Ayesha Pandit. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days

Indexed In






News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is November 30, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US